[Imidazoline receptor agonists: are they actual today?].
作者信息
Nebieridze D V, Kamyshova T V
出版信息
Kardiologiia. 2012;52(12):90-3.
PMID:23237448
Abstract
摘要
相似文献
1
[Imidazoline receptor agonists: are they actual today?].[咪唑啉受体激动剂：它们如今还实用吗？]
Kardiologiia. 2012;52(12):90-3.
2
[The significance of the sympathetic nervous system during therapy for hypertension and related pathologies. Imidazoline-I1-receptor agonists. 17th Scientific Meeting of the International Society of Hypertension. Amsterdam, June 7, 1998].[交感神经系统在高血压及相关病症治疗中的意义。咪唑啉-I1-受体激动剂。国际高血压学会第17届科学会议。阿姆斯特丹，1998年6月7日]
Dtsch Med Wochenschr. 1998 Aug 14;123(33 Suppl):1-4.
3
Imidazoline antihypertensive drugs: selective i(1) -imidazoline receptors activation.咪唑啉类降压药：选择性 i(1) -咪唑啉受体激动剂。
Cardiovasc Ther. 2012 Aug;30(4):209-16. doi: 10.1111/j.1755-5922.2011.00269.x. Epub 2011 Mar 23.
4
[Central nervous system as a target for the new antihypertensive agents].
Duodecim. 1999;115(20):2267-73.
5
Imidazoline Receptor Agonists for Managing Hypertension May Hold Promise for Treatment of Intracerebral Hemorrhage.用于治疗高血压的咪唑啉受体激动剂可能对治疗脑出血具有前景。
Curr Mol Med. 2018;18(4):241-251. doi: 10.2174/1566524018666180926163712.
6
Antihypertensive treatment and sympathetic excitation.抗高血压治疗与交感神经兴奋
Hypertension. 2005 Sep;46(3):e8; author reply e8. doi: 10.1161/01.HYP.0000176234.17554.c0.
7
Selective imidazoline receptor agonists for metabolic syndrome.
Lancet. 1998 Jan 17;351(9097):152-3. doi: 10.1016/S0140-6736(98)22003-4.
8
[Renoprotecion With Metabolic Syndrome: the Possibility of Receptor Agonist Imidazoline Moxonidine].[代谢综合征的肾脏保护作用：咪唑啉受体激动剂莫索尼定的可能性]
Kardiologiia. 2016 Oct;56(10):72-79. doi: 10.18565/cardio.2016.10.72-79.
9
[Hypertension and the sympathetic nervous system - recent developments in research and treatment].[高血压与交感神经系统——研究与治疗的最新进展]
Dtsch Med Wochenschr. 2009 Nov;134(45):2289-93. doi: 10.1055/s-0029-1241941. Epub 2009 Oct 29.
10
[Renal sequelae of sympathetic hyperactivity].[交感神经过度活跃的肾脏后遗症]
Wien Med Wochenschr. 2004;154 Spec No 1(1):7-9.
Zotero 插件